Latest 23andMe Stories
Erynn Gordon to Oversee Engagement with Medical Community and Key Clinical Applications as Medical Marketing Director MOUNTAIN VIEW, Calif., March 19, 2015
NEW YORK, March 16, 2015 /PRNewswire/ --Kalorama information suggests that the FDA approval of a rare gene test from Mountain View, Calif.-based personal genetics company 23andMe will open the
First ever genome-wide association study on common, incurable skin condition pinpoints two genetic variants associated with rosacea MOUNTAIN VIEW, Calif., March 10, 2015 /PRNewswire/
Privacy and Health Information Technology Expert Joins 23andMe Leadership Team MOUNTAIN VIEW, Calif., Feb.
BRONX, N.Y., Feb.
23andMe's Personal Genome Service® 510(k) Submission for Bloom Syndrome Carrier Status Test Report Granted Marketing Authority through De Novo Classification MOUNTAIN VIEW, Calif.,
First ever genome-wide association study on motion sickness links 35 genetic variants to the condition; some variants display stronger effects in women MOUNTAIN VIEW, Calif., Feb.
Agreement Provides Pfizer with Access to 23andMe's Research Portal; Companies to Establish New Lupus Research Community in 2015 MOUNTAIN VIEW, Calif., Jan.
Collaboration Aims to Generate New Therapeutic Approaches for Chronic Diseases SAN FRANCISCO, Jan.
- Large; stout; burly.